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ABSTRACT 
Background: The response to stroke in Nigeria is impaired by inadequate epidemiologic 
information. We sought to collate available evidence and estimate the incidence of stroke and 
prevalence of stroke survivors in Nigeria. 
Methods: Using random effects meta-analysis, we pooled nationwide and regional incidence 
and prevalence of stroke from the estimates reported in each study. 
Results: Eleven studies met our selection criteria. The pooled crude incidence of stroke in 
Nigeria was 26.0 (12.8-39.0) /100,000 person-years, with this higher among men at 34.1 (9.7-
58.4) /100,000, compared to women at 21.2 (7.4-35.0) /100,000. The pooled crude prevalence 
of stroke survivors in Nigeria was 6.7 (5.8-7.7) /1000 population, with this also higher among 
men at 6.4 (5.1-7.6) /1000, compared to women at 4.4 (3.4-5.5) /1000. In the period 2000-2009, 
the incidence of stroke in Nigeria was 24.3 (95% CI: 11.9-36.8) per 100,000, with this increasing 
to 27.4 (95% CI: 2.2-52.7) per 100,000 from 2010 upwards. The prevalence of stroke survivors 
increased minimally from 6.0 (95% CI: 4.6-7.5) per 1,000 to 7.5 (95% CI: 5.8-9.1) per 1,000 over 
the same period. The prevalence of stroke survivors was highest in the South-south region at 
13.4 (9.1-17.8) /100,000 and among rural dwellers at 10.8 (7.5-14.1) /100,000 
Conclusion: Although study period does not appear to contribute substantially to variations in 
stroke morbidity in Nigeria, an increasing number of new cases compared to survivors may be 
due in part to limited door-door surveys, or possibly reflects an increasing mortality from stroke 
in the country. 
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HIGHLIGHTS 
 There is very limited epidemiologic evidence on stroke morbidity in Nigeria. 
 From crude estimates, new stroke cases appear to increase at relatively higher rates 
compared to stroke survivors. 
 This possibly reflects inadequate door-to-door surveys, or an increasing mortality from 
stroke, both with implications for public health policy and planning. 
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INTRODUCTION 
Stroke is a leading contributor to global disease morbidity and mortality (1). More than 
6.5 million deaths and 113.2 million disability-adjusted life years (DALY) were attributable to 
stroke in 2013 (1, 2). Recent epidemiological trends revealed that global survivors for both 
ischemic and hemorrhagic stroke increased to 25.7 million in 2015, particularly in high-income 
countries (3). There are also new dimensions to these recent estimates. During the last decade, 
incidence rates and deaths from stroke in high-income countries have modestly diminished or 
plateaued resulting in about 42% reduction in overall stroke burden between 1970 and 2008 (4). 
In contrast, the burden of stroke has increased at an astonishingly fast rate in low- and middle-
income countries (LMICs), with the steepest increase in stroke prevalence occurring in low-
income countries of Africa, increasing by 6% annually (5). This evidence underscores a need for 
targeted effort by all stakeholder in these jurisdictions. 
In Nigeria and across many African countries, the increasing burden of stroke has been 
attributed to epidemiologic and demographic transitions driven in part by both rural–urban drift 
and rapid economic development (4). The resulting population growth, ageing, physical 
inactivity and consumption of processed foods high in cholesterol and salt have contributed to 
increasing number of stroke cases seen in the last two decades (4). Simultaneously, inadequate 
neurological services and the high cost of health services remain serious challenges in many 
settings (6). In Nigeria particularly, the rising prevalence of cardiovascular risk factors, poor 
awareness of early stroke signs, high cost and poor uptake of computed tomography (CT) and 
magnetic resonance imaging (MRI) scans, have resulted in a rising 30-days stroke fatality (7).  
Presently, there is insufficient information on the epidemiology of stroke in Nigeria (8, 9). Many 
stakeholders have advocated for accurate, up-to-date information on stroke incidence and 
survivorship to assist in identifying individuals, groups, or geographic areas that are at increased 
risk or poorer outcomes of stroke in the country. This study, therefore, aims to estimate the 
incidence of stroke and prevalence of stroke survivors in Nigeria to prompt improved policy 
response and public health intervention across at states and national levels.  
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METHODS 
Search strategy 
Database searches were conducted on 01 August 2018 and limited to studies published after 1 
January 1990. We searched MEDLINE, EMBASE, Global Health, and Africa Journals Online 
(AJOL), for epidemiologic studies or reports on stroke in Nigeria. Search terms employed are 
shown in Table 1. Unpublished documents were sourced from Google Scholar and general 
Google searches. Titles and abstracts of studies were screened, and full-texts of relevant 
studies accessed. Reference lists of full-texts were further hand-searched for additional studies. 
We contacted authors of selected papers for any missing information. 
Selection criteria 
Studies that met inclusion were primarily population-based studies, community-based door-to-
door surveys, or outpatient hospital surveys reporting on the prevalence or incidence of stroke 
in a Nigerian setting. We excluded studies on Nigerians in diaspora, case-reports, reviews, 
view-points or commentaries. 
Case definitions 
Stroke was defined according to standard WHO case definition: “rapidly developing clinical 
signs of focal (or global) disturbance of cerebral function lasting longer than 24 hours, unless 
interrupted by death, with no apparent cause other than that of vascular origin” (4, 10). We 
classified new cases of stroke as persons presenting with first ever stroke in a given period, 
while stroke survivors were the total number of people who have had stroke or living with its 
sequelae at a given time. 
Data Extraction 
Assessment of eligible studies was conducted separately by two reviewers (DA and AA), with a 
standardized eligibility guideline to ensure consistency. Any disagreement in study selection 
was resolved by consensus. Data on the location, study period, study design, study setting 
(urban or rural), sample size, diagnostic criteria and mean age of the population were extracted. 
These were matched with corresponding data on stroke cases (new or survivors), sample 
population (or person years of follow-up), and incidence or prevalence of stroke as reported in 
each study. For studies conducted on the same study site, population or cohort, the first 
published study was selected, and all additional data from the other studies were extracted and 
merged with data from the selected paper.  
Quality Assessment 
For each full text selected, we further screened for explicit description of methodology, case 
definitions of stroke, and generalizability of reported estimates to a larger population within the 
geo-political zone. For the quality grading, we adapted a previously used quality assessment 
criteria for studies examining the prevalence of chronic diseases (11-14). For each full-text 
manuscript selected, we screened for sampling strategy to identify if it was representative of a 
target subnational population, statistical methods (was it appropriate for the study outcome?), 
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and stroke case ascertainment (was it based on standard diagnostic criteria, unspecified clinical 
criteria, informant interviews, or not reported?). Studies were graded as high (4-5), moderate (2-
3), or low quality (0-1) (see Tables 2 and 3, for details of all full-text manuscripts accessed and 
quality grading).  
Data Analysis 
A random effects meta-analysis, using the DerSimonian and Laird Method (15), was employed 
on the individual study estimates to generate national and sub-national summary estimates of 
incidence of stroke (expressed per 100000 person years (py)), or prevalence of survivors in 
Nigeria (expressed per 1000 population). Standard errors were determined from the reported 
crude estimates and population denominators, assuming a binominal (or Poisson) distribution. 
Heterogeneity between studies was assessed using I-squared (I2) statistics, and subgroup 
analysis was conducted to detect causes of heterogeneity. Our approach to data analysis has 
been described in detail in previous studies (17, 18). All statistical analyses were conducted on 
STATA (Stata Corp V.14, Texas, USA). The study was conducted in strict compliance to the 
PRISMA guidelines (19). 
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RESULTS 
Search results 
Our searches identified 1199 potentially eligible studies (MEDLINE: n=522, EMBASE: n=650, 
Global Health: n=15, and AJOL: n=7). Five additional studies were identified through Google 
Scholar, and an examination of the reference lists of relevant studies. After duplicates have 
been removed, 602 titles were screened for relevance (i.e. any population-based or hospital-
based studies on stroke in Nigeria). On applying the selection criteria, 533 studies were 
excluded. We then assessed 69 full-texts assessed following which another 58 studies were 
excluded. Eleven studies (6, 20-29) were finally selected for the review (Figure 1). 
Study characteristics 
Of the 11 retained studies, there were nine population-based surveys, while two were hospital-
based. Four studies were retrieved from South-west Nigeria, three from the South-south, and 
two each from the North-central and South-east. There were no studies from the North-east and 
North-west. Six studies were conducted in urban settings, three in rural and two in semi-urban 
settings. Five studies were rated as high quality, while six were rated moderate. These 11 
studies yielded 38 data points, 10 reporting incidence (which were mainly conducted in the 
South-west) and 25 pertaining to stroke survivors. Study period ranged from 1995 to 2016, with 
most studies conducted within a one-year period. The estimated person-years of follow-up from 
all studies was 1,242,137 and the total population covered among stroke survivors was 41,143. 
Mean age ranged from 26.9 to 58.2 years (Table 3). Heterogeneity was high across studies, 
with an I-squared (I2) estimated at 100% and 97.7% for studies on new cases, and survivors, 
respectively (p=0.001 for both). 
Pooled incidence of stroke in Nigeria 
The estimated pooled crude incidence of stroke in Nigeria from all studies (1995-2016) was 26.0 
(95% CI: 12.8-39.0) per 100,000 py (Figure 2A, Table 4). The incidence of stroke in men was 
higher at 34.1 (95% CI: 9.7-58.4) per 100,000 py, while women had an estimated incidence of 
21.2 (95% CI: 7.4-35.0) per 100,000 py (Table 4). As all prevalence studies were reported 
mainly in the South-west, we did not conduct a sub-group analysis by geo-political zones. 
However, the incidence of stroke was highest among urban dwellers at 26.8 (95% CI: 75.1-80.5) 
per 100,000 py, while persons living in semi-urban settings (a mix of urban and rural 
environments) had a stroke incidence of 17.4 (95% CI: 15.2-19.6) per 100,000 py. There was no 
reported incidence in core rural settings (Figure 2B, Table 4 In the period 2000-2009, the 
incidence of stroke in Nigeria was 24.3 (95% CI: 11.9-36.8) per 100,000, with this increasing to 
27.4 (95% CI: 2.2-52.7) per 100,000 in the period 2010 upwards (Figure 2C, Table 4). 
Pooled prevalence of stroke survivors in Nigeria 
As noted, there were more data points on stroke survivors, possibly reflecting the relative ease 
of identifying cases from community-based door-to-door surveys. The estimated pooled crude 
prevalence of stroke survivors in Nigeria was 6.7 (95% CI: 5.8-7.7) per 1,000 population (Figure 
3A, Table 4). As observed for incident cases, the pooled crude prevalence of stroke survivors 
8 
 
was higher among men at 6.4 (95% CI: 5.1-7.6) per 1,000 compared to the pooled prevalence 
among women at 4.4 (95% CI: 3.4-5.5) per 1,000. Further sub-group analysis by geo-political 
zones in Nigeria showed that the South-south region had the higher prevalence of stroke 
survivors at 13.4 (95% CI: 9.1-17.8) per 1,000, followed by the South-east at 8.9 (95% CI: 3.4-
14.5) per 1,000. The North-central and South-west zones had prevalence of 4.8 (95% CI: 2.7-
6.9), and 2.9 (95% CI: 1.7-4.1) per 1,000, respectively. The prevalence of stroke survivors was 
higher in rural settings at 10.8 (95% CI: 7.5-14.1) per 1,000, while estimated prevalence in 
urban settings was 6.2 (95% CI: 4.6-7.9) per 1,000 (Figure 3B, Table 4). The prevalence of 
stroke survivors increased minimally from 6.0 (95% CI: 4.6-7.5) per 1,000 to 7.5 (95% CI: 5.8-
9.1) per 1,000 over the period 2000-2009 and 2010 upwards (Figure 3C, Table 4). 
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DISCUSSION 
The findings from this study revealed important information that mirrors the huge burden of 
stroke reported across sub-Saharan African countries (5). First, we found that the overall age-
adjusted prevalence of stroke survivors in Nigeria was 674/100,000 population. This estimate is 
almost double the global estimate of 393.4/100,000 reported by Feign and colleagues in 2014, 
and also relatively higher than the ranges recorded in some LMICs (550/100,000) (30). Although 
the substantially higher estimate of stroke survivors may have been biased by 
underrepresentation of fatal cases, which have been noted in previous reports (7). Second, 
there was a significant variation in the prevalence of stroke survivors across regions and 
calendar years in Nigeria. Specifically, we found a higher prevalence trend among rural dwelling 
adults particularly in the South-south region compared to other regions or population groups in 
Nigeria. The evidence is also well situated in a previous survey of stroke prevalence, where a 
positive association was reported between cardiovascular diseases including stroke and 
environmental risks in the oil-rich rural South-south (Niger-Delta) region of Nigeria (31, 32). 
Hence, apart from lifestyle factors, this suggests increasing risks for stroke associated with 
exposure to environmental pollution in areas that host oil and gas production and refining 
operations in Nigeria. This finding is consistent with the estimates found in some low-income 
countries, in line with the convergence of increasing income levels, rural-to-urban 
transformation, and high industrial outputs towards cardio-vascular disease predictors (33). 
 
When crude estimates were disaggregated by study period (ie. before and after year 2010), 
there were not so much difference in the incidence and prevalence rates, suggesting that year 
may not contribute substantially to variations in the morbidity of stroke in Nigeria (a fact further 
highlighted in an epidemiologic model we ran, see supplementary material). However, 
compared to a minimal increase observed among stroke survivors (6.0 to 7.5 per 100,000), 
crude incidence rates of stroke showed relatively higher increase, from 24.3 to 27.4 per 1000 
before and after year 2010, respectively. This perhaps reflects an increasing mortality from 
stroke and/or limited capture of stroke survivors from household surveys, both with implications 
for public health policy and planning. Besides, the observed increase may be related to early 
stages of epidemiological transition Nigeria and indeed many LMICs are currently experiencing, 
characterized by higher rates of stroke and coronary deaths (5, 30). As noted, this has been 
linked to population-wide increased consumption of processed foods, higher salt intake, tobacco 
smoking, harmful use of alcohol, and sedentary lifestyles (34). Evidence of these changes in the 
country has come to the fore with a rising burden of cardiovascular outcomes including stroke 
mortality and morbidity as reported in this study and previously (4, 5, 7). The stroke rate found in 
this study is similar to the estimates from developing countries like Zimbabwe and Libya, 
however, this is lower in global age-adjusted annual incidence for LMICs, possibly reflecting 
poor data representation in many parts of the country (2). For instance, the age-adjusted 
incidence of stroke in countries like South Africa, Tanzania and Egypt ranges from 101 to 260 
per 100,000 (30).  
 
This portends huge burden to the overall health and economic development in Nigeria. This 
economic impact stems from increased out-of-pocket expenditure, loss of individual and family 
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productivity and reduced labour efficiency, thus culminating in underinvestment in other critical 
social infrastructure and GDP losses nationally. Developing a comprehensive nation-wide plan 
to address stroke and other NCDs, particularly through the promotion of healthy lifestyles 
among young adults and ensuring services are also available for rural dwellers, may provide a 
cost-effective approach to reducing this burden in the coming years (35-38). 
 
This study has some important limitations to consider. First, our estimates and confidence 
intervals reflect wide uncertainties. This generally should guide the interpretation of our findings. 
The lack of data across many settings and calendar years is partly attributable, largely reflective 
of poor stroke infrastructure, especially stroke specialist registries, to track stroke cases 
particularly in rural areas. Second, in addition to lack of stroke registries, hospital-based data 
often may be inadequate to estimate incident cases due in part to unknown denominator or 
population at risk. Under-representation of cases could also be due to poor access to hospital 
services often related to distance and out-of-pocket costs for stroke services and care (39, 40). 
Third, although hospital-based studies are relatively preferred in the absence of stroke registry 
to investigate stroke incidence (34, 41), there were however insufficient information from most 
hospital-based studies to understand if these estimates were recurrent or first-ever strokes. 
Further, there were no studies from the North-east and North-west regions of Nigeria, and 
several important study characteristics including age- and sex-specific estimates were not 
always provided in studies. Thus, results arising from fewer data points may lean towards 
publication bias, underreporting of important metrics, and doubts on regional population 
representation. 
 
However, this study also has important strengths. First, we applied a strict quality assessment 
based on methodological rigours in the selection of studies, ensuring only moderate to high 
quality studies were included in the analysis. This has important considerations in reducing bias 
from poorly designed studies, varying case definitions and poor population representation. 
Second, we applied a comprehensive systematic search of different databases to ensure the 
identification of relevant articles. Thus, this study has provided an updated information on the 
epidemiology of stroke in Nigeria, on which further research efforts can be established. 
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CONCLUSION 
This study suggests incident cases and survivors from stroke may be increasing in Nigeria, and 
significantly vary across regions. The rise in stroke prevalence in the rural communities in 
Nigeria suggests that the risks for stroke may no longer be limited to urban dwellers. Public 
health awareness and other interventions for rural dwellers and other vulnerable population 
groups may be highly useful. It is hoped that the evidence provided in this study may inform 
relevant decisions, policy reforms and population-wide intervention towards reducing the burden 
of stroke across Nigeria. 
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FIGURE LEGENDS 
FIGURE 1. Flow chart of selection of studies on stroke in Nigeria. 
FIGURE 2. A. Pooled crude incidence of stroke in Nigeria, per 100,000 person years; A. Pooled 
crude incidence of stroke in Nigeria, per 100,000 person years (by study settings); A. Pooled 
crude incidence of stroke in Nigeria, per 100,000 person years (by study period). 
FIGURE 3. A. Pooled crude prevalence of stroke survivors in Nigeria, per 1000 population (by 
geographic zones); B. Pooled crude prevalence of stroke survivors in Nigeria, per 1000 
population (by study settings); C. Pooled crude prevalence of stroke survivors in Nigeria, per 
1000 population (by study period). 
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FIGURE 1. Flow chart of selection of studies on stroke in Nigeria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through database search (n = 
1194) 
• MEDLINE (522) 
• EMBASE (650) 
• Global Health- CABI (15) 
• AJOL (7) 
Full-text articles excluded (n = 58) 
• Studies without prevalence or 
incidence estimates of stroke (44) 
 
• Core clinical studies (14)  
Studies included  
(n = 11) 
 Google Scholar and other sources  
(n = 5) 
Articles screened (after duplicates removed)  
(n = 402) 
Articles excluded (n = 333) 
• General neurological studies (257) 
• Reviews, letters and editorials (60) 
• Opinions or view-points (16) 
  
Full-text articles assessed for eligibility  
(n = 69) 
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FIGURE 2. A. Pooled crude incidence of stroke in Nigeria, per 100,000 person years; B. Pooled 
crude incidence of stroke in Nigeria, per 100,000 person years (by study settings); C. Pooled 
crude incidence of stroke in Nigeria, per 100,000 person years (by study period). 
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FIGURE 3. A. Pooled crude prevalence of stroke survivors in Nigeria, per 1000 population (by 
geographic zones); B. Pooled crude prevalence of stroke survivors in Nigeria, per 1000 
population (by study settings); C. Pooled crude prevalence of stroke survivors in Nigeria, per 
1000 population (by study period). 
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TABLE 1. Search terms on stroke in Nigeria 
# Searches 
1 africa, sub-sahara/ or africa, western/ or nigeria/ 
2 exp vital statistics/ 
3 (incidence* or prevalence* or morbidity or mortality).tw. 
4 (disease adj3 burden).tw. 
5 exp "cost of illness"/ 
6 case fatality rate.tw 
7 hospital admissions.tw 
8 Disability adjusted life years.mp. 
9 (initial adj2 burden).tw. 
10 exp risk factors/ 
11 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 
12 exp stroke / or brain infarction / or cerebrovascular 
accident / or cerebrovascular disease / or transient 
ischemic attack 
13 1 and 11 and 12 
14 Limit 13 to “1990-current” 
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TABLE 2. Quality assessment of selected studies 
Quality criteria Assessment Score Maximum score 
Sampling method (was it 
representative of a target 
subnational population?) 
Yes 1 1 
No 0 
Appropriateness of 
statistical analysis 
Yes 1 1 
No 0 
Case ascertainment (was it 
based on standard 
diagnostic criteria, other 
clinical criteria or case 
definition, informal 
interviews, or not 
reported?) 
Standard diagnostic 
criteria 
3 3 
Other clinical criteria or 
case definition 
2 
Informal interviews 1 
Not-reported 0 
Total (high (4-5), moderate (2-3), or low quality (0-1)) 5 
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TABLE 3. Characteristics of studies on epidemiology of stroke in Nigeria 
Author Year Location Geopolitical 
zone 
Study design Study 
Setting 
Quality 
Adedoyin & 
Adesoye (20) 
2001 Ile-Ife, Osun State South-west Hospital-based retrospective 
study 
Semi-Urban Moderate 
Ansa et al (21) 1995 Calabar, Cross River 
State 
South-south Hospital-based retrospective 
study 
Urban Moderate 
Danesi et al (22) 2007 Lagos South-west Population-based door-to-door 
survey 
Urban High 
Danesi et al (23) 2006 Surulere, Lagos South-west Population-based door-to-door 
survey 
Urban High 
Enwereji et al (24) 2014 Anambra State South-east Population-based door-to-door 
survey 
Rural High 
Ezejimofor et al(6) 2014 Niger Delta, Delta 
State 
South-south Community-based cross-
sectional study 
Rural High 
Ojji et al (25) 2010 Abuja, FCT North-central Prospective cohort study Urban Moderate 
Okon et al (26) 2011 Akure, Ondo State South-west Prospective cohort study Urban Moderate 
Onwuchekwa et al 
(27) 
2008 Kegbara-Dere, 
Rivers State 
South-south Community-based cross-
sectional study 
Rural High 
Sanya et al (28) 2010 Ilorin, Kwara State North-central Community-based door-to-
door study 
Semi-urban Moderate 
Ezeala-Adikaibe et 
al (29) 
2016 Enugu State South-east Population-based cross-
sectional study 
Urban High 
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Table 4. Pooled crude estimates of incidence and prevalence of stroke in Nigeria 
Data Both sexes  Men  Women  
Pooled rate 
(95% CI) 
I2, P-
value 
Pooled 
rate 
(95% CI) 
I2, P-
value 
Pooled 
rate (95% 
CI) 
I2, P-
value 
Incidence of 
stroke (per 
100,000 
person years) 
Nation-wide 25.9 (12.8-
39.0) 
100, 
<0.001 
34.1 (9.7-
58.4) 
99.8, 
<0.001 
21.1 (7.4-
35.0) 
99.7, 
<0.001 
Study 
period 
2000-2009 24.3 (11.9-
36.8) 
100, 
<0.001 
    
2010+ 27.4 (2.2-
52.7) 
100, 
<0.001 
    
Settings Urban 26.8 (13.0-
40.6) 
100, 
<0.001 
- - - - 
Semi-
urban 
17.4 (15.2-
19.6) 
-,  - - - - 
Rural - - - - - - 
Prevalence of 
stroke 
survivors (per 
1000 
population) 
Nation-wide 6.7 (5.8-7.7) 97.7, 
<0.001 
6.4 (5.1-
7.6) 
95.3, 
<0.001 
4.4 (3.4-
5.5) 
96.0, 
<0.001 
Study 
period 
2000-2009 6.0 (4.6-7.5) 96.9, 
<0.001 
    
2010+ 7.5 (5.8-9.1) 98.2, 
<0.001 
    
Settings Urban 6.2 (4.6-7.9) 98.3, 
<0.001 
- - - - 
Semi-
urban 
4.8 ((2.5-7.1) 96.6, 
<0.001 
- - - - 
Rural 10.8 (7.5-
14.1) 
97.5, 
<0.001 
- - - - 
Geo-
political 
zones 
North-
central 
4.8 (2.7-6.9) 96.8, 
<0.001 
- - - - 
South-
east 
8.9 (3.4-14.5) 98.4, 
<0.001 
- - - - 
South-
south 
13.4 (9.1-
17.8) 
97.4, 
<0.001 
- - - - 
South-
west 
2.9 (1.7-4.1) 95.1, 
<0.001 
- - - - 
 
 
